Cosmederm Bioscience announced that a study recently published in the journal Acta Dermato-Venereologica has established its TriCalm anti-itch product has greater anti-itch efficacy as compared with products containing hydrocortisone or diphenhydramine.

i-Health released an adult-strength chewable version of their probiotic brand — Culturelle Digestive Health Probiotic Chewables.

Swiss drug maker Covis Pharma will buy U.S. rights to five drugs from Sanofi, Covis said.

Birchwood Laboratories on Wednesday launched B-Sure Absorbent Pads, a thin and highly absorbent alternative to diaper-like undergarments that provide a discreet solution to light fecal incontinence associated with childbirth.

The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said.

A ruling by India's high court means cheaper generic versions of a cancer drug will remain available in developing countries, according to published reports.

The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

The Food and Drug Administration has approved a new drug made by Johnson & Johnson for treating Type 2 diabetes, the agency said.

Hamacher Resource Group has been invited to present a continuing education session, “Bottom Line Performance: Opportunities and Actions,” at the Mutual Drug Spring CE Forum on April 7 in Raleigh, N. C., the company announced.

The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

Pharmacies using McKesson EnterpriseRx pharmacy-management system can send patients information about health clinics, drug recalls, coupons and real-time surveys through their mobile phones using an integrated mobile communication system.

GNC extended its Preventive Nutrition brand to help supplement a number of conditions, including eye health, liver health and digestive health.